SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (915)2/11/2004 1:17:50 PM
From: tuck   of 1005
 
What the hell, then. If we figure that EYET execs might also have such reservations about the marketability of their treatment, then they'll probably start bailing at the first opportunity. They apparently have have an option to distribute ISIS' Macugen for CMV (I haven't looked at the details). Big whoop.

BLUE HP opens it's first short: 300 shares at $30.10.

Note that this is going to screw up the portfolio's value figures until it's closed, which could be a while.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News